Chembio Diagnostics, Inc. Donates HIV Tests to Support World AIDS Day 2008 Testing Initiative

MEDFORD, NY--(Marketwire - December 01, 2008) - Chembio Diagnostics, Inc. (OTCBB: CEMI) ("Chembio" or the "Company") joined AIDS Healthcare Foundation (AHF) in the World AIDS Day 2008 global effort to test one million people from November 26 through December 1, 2008. Based in Los Angeles, AHF provides state-of-the-art medicines and advocacy to over 85,000 people in 22 countries and is the nation's largest provider of HIV/AIDS medical care. Chembio is supporting these efforts by providing approximately 20,000 HIV 1/2 STAT-PAK® tests to testing programs in 3 countries. Chembio's HIV 1/2 STAT-PAK® and HIV 1/2 STAT-PAK® Dipstick tests are ideally suited for point-of-care testing with a simple test protocol, long shelf life, minimum sample requirements for venous or finger-stick whole-blood, plasma or serum, test results in < 10 minutes and room temperature storage requirements. Chembio has also completed development of an HIV test on its patented Dual Path Platform (DPP®) that can be used with oral fluid or blood samples.
MORE ON THIS TOPIC